These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7737009)

  • 1. [Transdermal administration of drugs--are there enough places for patches?].
    Paakkari I
    Duodecim; 1993; 109(20):1867-74. PubMed ID: 7737009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transdermal drug administration].
    Fankhauser P; Imhof P; Shaw JE
    Ther Umsch; 1982 Nov; 39(11):857-67. PubMed ID: 7179171
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of polymers for dermal and transdermal delivery.
    Valenta C; Auner BG
    Eur J Pharm Biopharm; 2004 Sep; 58(2):279-89. PubMed ID: 15296955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Themed issue: Recent advances in transdermal drug delivery.
    Jones DS; Moss GP
    J Pharm Pharmacol; 2010 Jun; 62(6):669-70. PubMed ID: 20636852
    [No Abstract]   [Full Text] [Related]  

  • 6. Transdermal drug delivery: past progress, current status, and future prospects.
    Langer R
    Adv Drug Deliv Rev; 2004 Mar; 56(5):557-8. PubMed ID: 15019745
    [No Abstract]   [Full Text] [Related]  

  • 7. Maximum flux versus transdermal delivery: comment on Farahmand and Maibach (2009).
    Kissel JC; Bunge AL
    Int J Pharm; 2010 Oct; 398(1-2):247-8. PubMed ID: 20600727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transdermal therapeutic systems].
    Losenkova SO
    Eksp Klin Farmakol; 2008; 71(6):54-7. PubMed ID: 19140519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced absorption through damaged skin: an overview of the in vitro human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2010; 23(4):171-6. PubMed ID: 20185974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking the skin barrier.
    Mitragotri S
    Adv Drug Deliv Rev; 2004 Mar; 56(5):555-6. PubMed ID: 15019744
    [No Abstract]   [Full Text] [Related]  

  • 12. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products.
    Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
    Skin Therapy Lett; 2012 Jun; 17(6):5-7. PubMed ID: 22735504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration properties and safety aspects of topically applied products.
    Fluhr J; Lademann J
    Skin Pharmacol Physiol; 2008; 21(6):293. PubMed ID: 18997482
    [No Abstract]   [Full Text] [Related]  

  • 14. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal drug patches. Delivering medications through the skin.
    Mayo Clin Womens Healthsource; 2005 Feb; 9(2):1-2. PubMed ID: 15689835
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in the use of ultrasound-mediated transdermal drug delivery.
    Boucaud A
    Drug Discov Today; 2004 Oct; 9(19):827-8. PubMed ID: 15381133
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concept and design of transdermal therapeutic systems].
    Asche H
    Schweiz Rundsch Med Prax; 1985 Mar; 74(11):257-60. PubMed ID: 3992093
    [No Abstract]   [Full Text] [Related]  

  • 18. Can biologically inspired patches yield a new age of transdermal delivery?
    Chang CC
    Ther Deliv; 2014 Apr; 5(4):373-5. PubMed ID: 24856163
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of complexes formation between drugs and penetration enhancers in transdermal delivery.
    Drakulić BJ; Juranić IO; Erić S; Zloh M
    Int J Pharm; 2008 Nov; 363(1-2):40-9. PubMed ID: 18675333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.